Corvus Pharmaceuticals Inc (CRVS) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

Corvus Pharmaceuticals Inc
CRVS
(Nasdaq - US)
Closed
8.94
+0.70 (+8.49%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
8.20
High
9.04
Low
8.06

Stats

Prev. Close

8.24

Open

8.20

Day's Range

8.06 - 9.04

52 Week Range

1.30 - 10.00

YTD Change

407.95%

1 Year Change

516.55%

Market Cap

574.48M

P/E Ratio

N/A

Volume

17,068

Beta

1.05

Sector

Health Technology

Industry

Pharmaceuticals Major

Economic CalendarAll Events

Time zone: GMT

Thursday, November 21st 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:00	USD	Existing Home Sales MoMOct	Medium	3.4%	0.8%	-1.3%
15:00	USD	Existing Home SalesOct	Medium	3.96M	3.93M	3.83M
17:25	USD	Fed Goolsbee Speech	Medium
17:30	USD	Fed Hammack Speech	Medium

Friday, November 22nd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:45	USD	S&P Global Manufacturing PMI FlashNov	Medium		48.8	48.5
14:45	USD	S&P Global Composite PMI FlashNov	Medium		54.3	54.1
14:45	USD	S&P Global Services PMI FlashNov	Medium		55.2	55

Latest News

featured

Zacks Investment ResearchNov 15, 2024

Corvus (CRVS) is on the Move, Here's Why the Trend Could be Sustainable

CRVS+8.49%

featured

Seeking AlphaNov 13, 2024

Corvus Pharmaceuticals: The Market Likes The Story

CRVS+8.49%

featured

Seeking AlphaNov 13, 2024

Corvus Pharmaceuticals, Inc. (CRVS) Q3 2024 Earnings Call Transcript

CRVS+8.49%

featured

Zacks Investment ResearchSep 11, 2024

Corvus Stock Up on Initiation of Phase III Lymphoma Study on Lead Drug

CRVS+8.49%

featured

Seeking AlphaSep 3, 2024

Corvus Pharmaceuticals Eyes Phase 3 Trials: Soquelitinib's Promise In PTCL

CRVS+8.49%

featured

Seeking AlphaAug 10, 2024

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2024 Earnings Call Transcript

CRVS+8.49%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker